Gene therapies could have a major impact, although the cost and complexities could inhibit their wide rollout, study authors said. New advancements in gene therapy and hematopoietic stem cell ...

Researchers from the Broad Institute and Massachusetts Institute of Technology (MIT) have engineered multi-tailed mRNAs that boost mRNA activity levels in cells by as much as 20x and last 2-3 times ...

(Reuters) -Moderna Inc will collaborate with privately-owned Life Edit Therapeutics Inc under an agreement to discover and develop mRNA gene-editing therapies, the companies said on Wednesday. The tie ...

Oligonucleotide-based drugs already come in many flavours. The newest of these now aims to edit mRNA one base at a time, by harnessing endogenous enzymes called adenosine deaminases acting on RNA ...

Moderna’s ambitions in messenger RNA technology include therapies that do their editing work inside the patient. To that end, the biotech company is starting an R&D collaboration with a division of ...

Part of the job as a pediatric hematologist for Michael P. Triebwasser, MD, PhD, is to take care of patients during their bone marrow transplantation. Just last week, he took care of a patient with a ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against ...

By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station. Thanks to international ...

Feb 22 (Reuters) - Moderna Inc MRNA.O said on Wednesday it had entered into a research and development collaboration with privately-owned Life Edit Therapeutics Inc to discover and develop mRNA ...